• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

Portola Pharmaceuticals Inc

+ Add to Watchlist

PTLA:US

24.1500 USD 0.1500 0.62%

As of 10:58:32 ET on 07/25/2014.

Snapshot for Portola Pharmaceuticals Inc (PTLA)

Open: 24.0900 Day's Range: 23.8500 - 24.3900 Volume: 36,668
Previous Close: 24.3000 52wk Range: 19.5900 - 31.4800 1-Yr Rtn: +1.64%

Stock Chart for PTLA

No chart data available.
  • PTLA:US 24.1400
  • 1D
  • 1M
  • 1Y
24.3000
Interactive PTLA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PTLA

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.3776
Est. EPS (USD) (12/2014) -3.4100
Est. PEG Ratio -
Market Cap (M USD) 994.31
Shares Outstanding (M) 41.12
30 Day Average Volume 462,993
Price/Book (mrq) 3.7013
Price/Sale (ttm) 66.2562
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/15/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PTLA

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for PTLA

Portola Pharmaceuticals, Inc. provides specialty pharmaceutical products. The Company develops novel therapeutics for thrombosis, hematologic disorders, and inflammation indications. Portola Pharmaceuticals operates in the United States.

Charles J HomcyCo-Chairman/Co-FounderHollings C RentonCo-Chairman
William LisChief Executive OfficerMardi C DierExec VP/CFO
More Company Profile & Key Executives for PTLA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil